scispace - formally typeset
Journal ArticleDOI

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor.

TLDR
Continuous intracerebral infusion of NGF over a period of four weeks can partly reverse the cholinergic cell body atrophy and improve retention of a spatial memory task in behaviourally impaired aged rats.
Abstract
In aged rodents, impairments in learning and memory have been associated with an age-dependent decline in forebrain of cholinergic function, and recent evidence indicates that the cholinergic neurons in the nucleus basalis magnocellularis, the septal-diagonal band area and the striatum undergo age-dependent atrophy. Thus, as in Alzheimer-type dementia in man, degenerative changes in the forebrain cholinergic system may contribute to age-related cognitive impairments in rodents. The cause of these degenerative changes is not known. Recent studies have shown that the central cholinergic neurons in the septal-diagonal band area, nucleus basalis and striatum are sensitive to the neurotrophic protein nerve growth factor (NGF). In particular, intraventricular injections or infusions of NGF in young adult rats have been shown to prevent retrograde neuronal cell death and promote behavioural recovery after damage to the septo-hippocampal connections. It is so far not known, however, whether the atrophic cholinergic neurons in aged animals are responsive to NGF treatment. We report here that continuous intracerebral infusion of NGF over a period of four weeks can partly reverse the cholinergic cell body atrophy and improve retention of a spatial memory task in behaviourally impaired aged rats.

read more

Citations
More filters
Journal ArticleDOI

Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease.

TL;DR: The decrease in NGF binding is compatible with the loss of cholinergic neurons reported in the striatum from PSP patients, and was not significantly decreased in the nucleus basalis of Meynert in either diseases.
BookDOI

Concepts in genetic medicine

TL;DR: Concepts in genetic Medicine , Concepts in genetic medicine , کتابخانه دیجیتال جندی شاپور اهواز
Journal ArticleDOI

CNS gene therapy and a nexus of complexity: systems and biology at a crossroads.

TL;DR: A detailed understanding of sustained NGF action in the normal and diseased CNS needs to be resolved before conclusions can be drawn regarding the utility of NGF gene therapy, and clinically and biologically sophisticated efforts to advance gene therapy for neurodegenerative diseases are compelled.
Journal ArticleDOI

Cholinergic marker deficits induced by lesions of the nucleus basalis of Meynert are attenuated by nerve growth factor in young, but not in aged, F344 rats

TL;DR: To investigate the efficacy of nerve growth factor (NGF) in promoting recovery from cholinergic damage, young and aged rats received NMDA-induced unilateral lesions of the nucleus basalis of Meynert and subcutaneous osmotic pumps connected to permanently implanted cannulas directed at the lateral ventricle ipsilateral to the lesion.
Journal ArticleDOI

Enhancement of angiogenic effect of co-transfection human NGF and VEGF genes in rat bone marrow mesenchymal stem cells.

TL;DR: In this article, the feasibility and efficacy of co-transfection of the human nerve growth factor (NGF) and vascular endothelial growth factor 165 (VEGF165) genes in rat bone marrow mesenchymal stem cells (BMSCs) was explored.
References
More filters
Journal ArticleDOI

Developments of a water-maze procedure for studying spatial learning in the rat

TL;DR: Developments of an open-field water-maze procedure in which rats learn to escape from opaque water onto a hidden platform are described, suggesting that they may lend themselves to a variety of behavioural investigations, including pharmacological work and studies of cerebral function.
Journal ArticleDOI

The Cholinergic Hypothesis of Geriatric Memory Dysfunction

TL;DR: Biochemical, electrophysiological, and pharmacological evidence supporting a role for cholinergic dysfunction in age-related memory disturbances is critically reviewed and an attempt has been made to identify pseudoissues, resolve certain controversies, and clarify misconceptions that have occurred in the literature.
Journal ArticleDOI

Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

TL;DR: It is suggested that fimbrial transections resulted in retrograde degeneration of cholinergic septo-hippocampal neurons and that NGF treatment strongly attenuated this lesion-induced degeneration.
Journal ArticleDOI

Nerve growth factor treatment after brain injury prevents neuronal death

TL;DR: Cholinergic neuronal degeneration after axotomy has been proposed to be due to the loss of a retrogradely transported neurotrophic factor, possibly nerve growth factor (NGF), and NGF was continuously infused into the lateral ventricles of adult rats that had received bilateral lesions of all cholinergic axons projecting from the medial septum to the dorsal hippocampus.
Related Papers (5)